Stockreport

Travelan Experiences Strong Q1 FY2018 Sales Growth

Immuron Limited - American Depositary Shares  (IMRN) 
US:NASDAQ Investor Relations: immuron.com/investor-centre/business-overview
PDF Key Highlights: Significant growth of sales for Immuron’s over-the-counter supplement Travelan® for Q1 2018 compared to Q1 2017 Travelan® US experienced a 197% increase [Read more]